Sartorius AG Stock Borsa Italiana
Stocks
1SRT3
DE0007165631
Advanced Medical Equipment & Technology
OTC Markets Traded|
Real-time Estimate
Tradegate
13:31:33 2026-10-12 EDT
|
5-day change | 1st Jan Change | ||
| 252.85 EUR | +0.14% |
|
0.00% | +5.38% |
| 11:44am | Sartorius AG : JP Morgan maintains a Buy rating | ZD |
| 10-08 | AlphaValue's positive view is not enough for Sartorius Stedim Biotech |  |
| Market Cap | 15.81B 17.7B 14.7B 13.37B 25.25B 1,713B 25.36B 177B 69.34B 873B 66.46B 65.01B 2,802B | P/E 2026 * |
68.2x | P/E 2027 * | 52.4x |
|---|---|---|---|---|---|
| Enterprise Value | 19.39B 21.71B 18.03B 16.4B 30.97B 2,101B 31.11B 217B 85.04B 1,071B 81.51B 79.73B 3,437B | EV / Sales 2026 * |
5.22x | EV / Sales 2027 * | 4.68x |
| Free-Float |
35.87% | Yield 2026 * |
0.31% | Yield 2027 * | 0.38% |
| Markets | Quality | ||
|---|---|---|---|
Xetra
| SRT3 | Delayed | |
CBOE
| SRT3d | Real-time | |
|
Tradegate
| SRT3 | Real-time | |
|
Börse Stuttgart
| SRT3 | Delayed | |
|
Boerse Muenchen
| SRT3 | Real-time | |
|
Deutsche Boerse AG
| SRT3 | Delayed | |
|
OTC Markets
| SUVPF | Delayed | |
|
London S.E.
| 0NIR | Delayed | |
|
CBOE
| 0NIR | Real-time | |
|
Swiss Exchange
| SRT3 | Delayed | |
|
Wiener Boerse
| SRT3 | End-of-day quote | |
|
Borsa Italiana
| 1SRT3 | End-of-day quote |
Last Transcript: Sartorius AG
| 1 day | +0.18% | ||
| Current month | -1.79% | ||
| 1 month | +7.95% | ||
| 3 months | +3.91% | ||
| 6 months | +17.06% | ||
| Current year | +5.38% |
| 1 month | 228.1 |  | 264 |
| Current year | 203.8 | | 264.6 |
| 1 year | 203.8 | | 264.6 |
| 3 years | 176.85 | | 381.4 |
| 5 years | 176.85 | | 612.2 |
| 10 years | 172.3 | | 612.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Grosse
CEO | Chief Executive Officer | 59 | 2025-06-29 |
Florian Funck
DFI | Director of Finance/CFO | 55 | 2024-03-31 |
Volker Niebel
COO | Chief Operating Officer | 70 | 2000-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Annette Becker
BRD | Director/Board Member | 62 | 2002-08-31 |
Lothar Kappich
CHM | Chairman | 69 | 2017-07-18 |
| Director/Board Member | 77 | 2011-11-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.14% | 0.00% | - | - | 17.7B | |
| -0.34% | -3.28% | +24.78% | +35.64% | 243B | |
| +0.22% | -0.87% | +6.90% | +4.68% | 155B | |
| +1.20% | +5.34% | -1.73% | +60.90% | 150B | |
| +1.14% | +1.45% | -54.70% | -11.56% | 61.93B | |
| +0.80% | -1.78% | +17.44% | +22.53% | 49.12B | |
| +1.25% | +5.82% | -16.25% | -17.42% | 48.78B | |
| +0.00% | -0.65% | +23.11% | +56.21% | 48.08B | |
| -0.48% | +4.00% | +3.04% | +36.49% | 47.95B | |
| -0.88% | -2.44% | +27.67% | +71.07% | 42.62B | |
| Average | +0.29% | +3.01% | +3.36% | +28.73% | 94.01B | |
| Weighted average by Cap. | +0.27% | +2.97% | +7.03% | +30.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.71B 4.16B 3.45B 3.14B 5.93B 402B 5.95B 41.55B 16.28B 205B 15.6B 15.26B 658B | 4.08B 4.57B 3.79B 3.45B 6.52B 442B 6.55B 45.67B 17.89B 225B 17.15B 16.78B 723B |
| Net income | 248M 278M 231M 210M 397M 26.91B 398M 2.78B 1.09B 13.72B 1.04B 1.02B 44.03B | 318M 356M 296M 269M 508M 34.44B 510M 3.56B 1.39B 17.56B 1.34B 1.31B 56.35B |
| Net Debt | 3.58B 4.01B 3.33B 3.03B 5.72B 388B 5.74B 40.08B 15.7B 198B 15.05B 14.72B 635B | 3.29B 3.68B 3.06B 2.78B 5.25B 356B 5.28B 36.81B 14.42B 182B 13.82B 13.52B 583B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-01 | €252.50 | +1.00% | 0 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SRT3 Stock
- 1SRT3 Stock
Select your edition
All financial news and data tailored to specific country editions
